Immunogenicity testing performed by a central reference laboratory plays a critical role in clinical trials, enabling accurate evaluation of a subject's immune response to drugs and vaccines.
At Dr. Dangs Central Lab, immunogenicity testing is supported by a dedicated team with extensive experience in ELISA-based assays, with capabilities spanning protocol customization, assay optimization, and method development to meet study-specific and sponsor-driven requirements.
To strengthen data integrity and comparability, pre-dose and post-dose samples are consistently analysed together, minimizing analytical variability. Testing workflows are governed by structured quality systems, with all manual laboratory steps meticulously documented using controlled laboratory notebooks to ensure full traceability and alignment with GCLP and applicable regulatory expectations. Through experienced personnel and optimized processes, quality control failures are minimized, supporting regulator-ready data outputs.
This quality-driven and methodical approach enables Dr. Dangs Lab to deliver high-confidence immunogenicity data while supporting complex and evolving clinical trial programs.
